1. Home
  2. PXED vs MRVI Comparison

PXED vs MRVI Comparison

Compare PXED & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phoenix Education Partners Inc.

PXED

Phoenix Education Partners Inc.

HOLD

Current Price

$25.83

Market Cap

980.1M

Sector

Real Estate

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$7.60

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PXED
MRVI
Founded
1976
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
980.1M
1.0B
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
PXED
MRVI
Price
$25.83
$7.60
Analyst Decision
Buy
Buy
Analyst Count
7
4
Target Price
★ $44.29
$4.13
AVG Volume (30 Days)
56.2K
★ 2.6M
Earning Date
04-07-2026
05-07-2026
Dividend Yield
★ 3.07%
N/A
EPS Growth
N/A
★ 14.29
EPS
★ 1.69
N/A
Revenue
N/A
★ $185,743,000.00
Revenue This Year
$3.85
$12.54
Revenue Next Year
$4.49
$7.87
P/E Ratio
$15.25
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$23.52
$2.55
52 Week High
$38.19
$9.42

Technical Indicators

Market Signals
Indicator
PXED
MRVI
Relative Strength Index (RSI) 30.31 55.31
Support Level $24.92 $5.54
Resistance Level $30.79 $9.42
Average True Range (ATR) 0.86 0.36
MACD -0.12 0.03
Stochastic Oscillator 12.24 79.22

Price Performance

Historical Comparison
PXED
MRVI

About PXED Phoenix Education Partners Inc.

Phoenix Education Partners Inc. is a mission-driven organization operating at the forefront of the rapidly evolving post-secondary education market. it is an online education provider and a pioneer in its field. The company benefits from the dynamic interplay between technological innovation, education, employment, and economic trends. It is focused on delivering personalized, career-relevant, and affordable education to its students through its flexible learning model, skills-aligned curriculum, and accessible tuition costs.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: